ng-nitroarginine methyl ester has been researched along with Carcinoma, Lewis Lung in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banegas, I; Carmona-Cortés, J; García-Lora, ÁM; Osuna, A; Quesada, A; Rodríguez-Gómez, I; Vargas, F; Wangensteen, R | 1 |
Cai, XH; Chen, J; Chen, YF; Du, L; Huang, S; Mei, K; Yin, XD; Yu, JR; Zhang, ZX; Zhao, X; Zhou, CY | 1 |
2 other study(ies) available for ng-nitroarginine methyl ester and Carcinoma, Lewis Lung
Article | Year |
---|---|
Effect of thyroid hormone-nitric oxide interaction on tumor growth, angiogenesis, and aminopeptidase activity in mice.
Topics: Aminopeptidases; Animals; Carcinoma, Lewis Lung; Cell Proliferation; Guanidines; Hemoglobins; Male; Mice; Mice, Inbred CBA; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Thyroid Hormones; Thyroxine | 2014 |
[Effect of nitric oxide derived from endothelial nitric oxide synthase on tumor angiogenesis].
Topics: AC133 Antigen; Animals; Antigens, CD; Carcinoma, Lewis Lung; Cell Count; Cells, Cultured; Endothelium, Vascular; Enzyme Inhibitors; Female; Glycoproteins; Mice; Mice, Inbred C57BL; Microvessels; Neoplasm Transplantation; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Peptides; Plasmids; Random Allocation; Stem Cells; Transfection; Tumor Burden; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2010 |